UNICA IRIS Institutional Research Information System

FRAU, JESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 272.841
NA - Nord America 11.058
AS - Asia 4.220
SA - Sud America 690
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 9
Totale 288.915
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 270.235
US - Stati Uniti d'America 10.909
SG - Singapore 1.743
CN - Cina 1.737
SE - Svezia 599
BR - Brasile 586
UA - Ucraina 581
DE - Germania 445
VN - Vietnam 268
GB - Regno Unito 262
FI - Finlandia 258
FR - Francia 128
KR - Corea 96
CA - Canada 87
IN - India 73
NL - Olanda 72
HK - Hong Kong 50
AR - Argentina 42
MX - Messico 41
AT - Austria 40
RU - Federazione Russa 39
PL - Polonia 35
BD - Bangladesh 33
ES - Italia 32
CZ - Repubblica Ceca 29
ZA - Sudafrica 29
IQ - Iraq 25
MA - Marocco 23
TR - Turchia 22
JP - Giappone 20
EC - Ecuador 18
BE - Belgio 17
EU - Europa 17
PK - Pakistan 14
UZ - Uzbekistan 14
SA - Arabia Saudita 13
IR - Iran 12
ID - Indonesia 11
CO - Colombia 10
IL - Israele 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EG - Egitto 8
PH - Filippine 8
PS - Palestinian Territory 8
UY - Uruguay 8
VE - Venezuela 8
AZ - Azerbaigian 6
CL - Cile 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
IE - Irlanda 6
JO - Giordania 6
MD - Moldavia 6
OM - Oman 6
RS - Serbia 6
CR - Costa Rica 5
KZ - Kazakistan 5
MY - Malesia 5
PY - Paraguay 5
BG - Bulgaria 4
CH - Svizzera 4
DZ - Algeria 4
KE - Kenya 4
NP - Nepal 4
RO - Romania 4
TH - Thailandia 4
AL - Albania 3
BB - Barbados 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
LB - Libano 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
AD - Andorra 1
AM - Armenia 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DM - Dominica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MU - Mauritius 1
NA - Namibia 1
NZ - Nuova Zelanda 1
Totale 288.906
Salva come PNG Salva come JPEG
Città #
Cagliari 263.921
Uta 5.480
Ashburn 1.093
Fairfield 1.055
Woodbridge 784
Singapore 695
Dallas 600
Chandler 579
Houston 509
Wilmington 471
Boardman 461
Seattle 404
Cambridge 382
Beijing 377
Ann Arbor 365
Nyköping 349
Los Angeles 282
Chicago 277
Jacksonville 272
Dearborn 187
New York 173
Nanjing 153
Santa Clara 147
Helsinki 146
Munich 140
Hefei 137
Buffalo 135
Shanghai 132
Salt Lake City 124
Boston 117
Seoul 96
The Dalles 90
Milan 84
Ho Chi Minh City 78
Elk Grove Village 68
Tampa 63
San Diego 61
Norwalk 58
Shenyang 55
São Paulo 55
Rome 52
Nanchang 47
Dong Ket 46
Redwood City 46
Hong Kong 44
Guangzhou 42
Toronto 42
Washington 42
Atlanta 41
Redondo Beach 40
Jiaxing 39
London 39
Hebei 37
Hanoi 35
Sterling 35
Sassari 32
Phoenix 31
Verona 29
Brooklyn 28
Warsaw 28
Tianjin 27
Hangzhou 25
Lancaster 25
Nuremberg 25
Düsseldorf 24
Vienna 23
Miami 22
Changsha 21
Columbus 21
Stockholm 21
Domusnovas 20
Turku 20
Xi'an 20
Denver 19
Mountain View 19
Orem 19
Amsterdam 18
Council Bluffs 18
Mexico City 18
Montreal 18
Detroit 17
Johannesburg 17
Tokyo 17
Zhengzhou 17
Dulles 16
Frankfurt am Main 16
Jinan 16
Casablanca 15
Brno 14
Chennai 14
Da Nang 14
Florence 14
Poplar 14
Taizhou 14
Brussels 13
Rio de Janeiro 12
San Francisco 12
San Jose 12
Curitiba 11
Kunming 11
Totale 282.139
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.134
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.914
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.901
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.537
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.442
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.277
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.182
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.989
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.966
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.881
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.868
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.833
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.800
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.762
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.695
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.629
Walking improvements with nabiximols in patients with multiple sclerosis 3.623
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.589
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.558
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.548
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.541
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.471
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.381
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.375
Impact of the media on future hope in multiple sclerosis 3.353
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.273
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.265
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.259
Oral agents in multiple sclerosis 3.180
Influence of treatments in multiple sclerosis disability: a cohort study 3.148
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.136
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.072
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.032
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.001
Refining the connection between gait and cognition: training the body to improve the brain 2.944
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.941
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.927
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.850
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.833
Postural adaptation during a Nintendo Wii balance training 2.639
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.617
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.583
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.529
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.510
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.408
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.379
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.308
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.305
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.295
The cohort of the multiple sclerosis center of Cagliari 2.284
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.260
Induction and escalation therapies in multiple sclerosis 2.253
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.232
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.215
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.195
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.163
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study 2.097
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.060
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.057
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.011
Clinical activity after fingolimod cessation: disease reactivation or rebound? 1.941
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.910
Epidemiology of multiple sclerosis in south-western Sardinia 1.900
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.794
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.782
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.716
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis 1.705
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.676
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.635
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.619
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 1.592
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls 1.589
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 1.583
Association of Mycobacterium avium subsp. paratuberculosis and SLC11A1 polymorphisms in Sardinian multiple sclerosis patients 1.546
Association of Mycobacterium avium subsp paratuberculosis with Multiple Sclerosis in Sardinian Patients 1.545
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients 1.539
Timed Up and Go in men and women with Multiple Sclerosis: effect of muscular strength 1.497
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients 1.482
Monoclonal antibodies: a target therapy for multiple sclerosis 1.453
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.392
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.367
Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study 1.345
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.336
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 1.320
Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study 1.308
Progressive multiple sclerosis and mood disorders 1.296
Delayed effect of age at onset on disability progression in multiple sclerosis 1.282
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers 1.265
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 1.262
The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis 1.254
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up 1.234
PML in a person with multiple sclerosis: Is teriflunomide the felon? 1.197
Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia? 1.195
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis 1.178
The burden of multiple sclerosis and patients' coping strategies 1.148
Effect of different dosages of interferon beta-1a in relapsing remitting MS patients 1.123
Q10 in the CSF of MS patients 1.109
Coenzyme Q10 in the CSF of MS patients 1.102
Gait initiation evaluation in multiple sclerosis 1.081
Totale 251.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 350.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 350.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130.739 0 0 0 0 0 8.097 5.182 4.672 2.500 4.032 3.841 2.415
2021/202212.748 1.740 811 509 1.140 1.076 743 514 626 1.361 1.315 1.601 1.312
2022/202317.134 1.459 2.510 2.363 1.485 1.472 1.711 777 1.379 980 979 1.288 731
2023/202418.811 1.099 962 833 1.260 1.750 3.239 2.200 1.879 949 1.296 1.700 1.644
2024/202561.458 20.721 19.853 6.452 3.738 2.015 2.220 3.213 213 604 567 1.278 584
2025/20265.589 885 583 1.185 1.151 937 848 0 0 0 0 0 0
Totale 289.592